Teladoc Health (NYSE:TDOC) Hits New 52-Week Low on Disappointing Earnings

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) shares reached a new 52-week low on Friday after the company announced weaker than expected quarterly earnings. The stock traded as low as $12.65 and last traded at $13.36, with a volume of 2157832 shares trading hands. The stock had previously closed at $13.33.

The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The business had revenue of $646.13 million during the quarter, compared to the consensus estimate of $637.31 million. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The company's quarterly revenue was up 2.7% compared to the same quarter last year. During the same period last year, the firm earned ($0.37) EPS.

Wall Street Analysts Forecast Growth

TDOC has been the topic of several analyst reports. Stifel Nicolaus lowered their target price on shares of Teladoc Health from $21.00 to $16.00 and set a "hold" rating on the stock in a report on Friday. Truist Financial lowered their target price on shares of Teladoc Health from $23.00 to $17.00 and set a "hold" rating on the stock in a report on Wednesday, March 6th. Citigroup lowered their target price on shares of Teladoc Health from $21.00 to $19.00 and set a "neutral" rating on the stock in a report on Wednesday, February 21st. Canaccord Genuity Group reduced their price target on shares of Teladoc Health from $28.00 to $25.00 and set a "buy" rating on the stock in a research report on Friday. Finally, Oppenheimer reduced their price target on shares of Teladoc Health from $26.00 to $21.00 and set an "outperform" rating on the stock in a research report on Friday. Eleven investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Teladoc Health has a consensus rating of "Hold" and a consensus target price of $19.67.

Insider Activity

In other news, EVP Andrew Turitz sold 6,190 shares of the company's stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $89,878.80. Following the completion of the sale, the executive vice president now directly owns 39,429 shares of the company's stock, valued at approximately $572,509.08. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, insider Arnnon Geshuri sold 7,500 shares of the stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $15.06, for a total transaction of $112,950.00. Following the completion of the sale, the insider now directly owns 38,470 shares of the company's stock, valued at approximately $579,358.20. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Andrew Turitz sold 6,190 shares of the stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $89,878.80. Following the sale, the executive vice president now directly owns 39,429 shares of the company's stock, valued at $572,509.08. The disclosure for this sale can be found here. Insiders sold a total of 135,441 shares of company stock valued at $2,038,251 in the last ninety days. 1.63% of the stock is owned by insiders.

Institutional Trading of Teladoc Health

Large investors have recently bought and sold shares of the business. ICA Group Wealth Management LLC bought a new position in shares of Teladoc Health during the 4th quarter worth approximately $28,000. Hexagon Capital Partners LLC lifted its holdings in Teladoc Health by 204.4% during the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider's stock valued at $34,000 after purchasing an additional 1,065 shares during the last quarter. RIA Advisory Group LLC acquired a new stake in Teladoc Health during the 4th quarter valued at $36,000. GAMMA Investing LLC acquired a new stake in Teladoc Health during the 4th quarter valued at $41,000. Finally, Principal Securities Inc. acquired a new stake in Teladoc Health during the 4th quarter valued at $45,000. 76.82% of the stock is owned by institutional investors.

Teladoc Health Stock Down 2.4 %

The firm has a fifty day simple moving average of $15.01 and a 200-day simple moving average of $17.77. The firm has a market cap of $2.20 billion, a price-to-earnings ratio of -9.71 and a beta of 0.94. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.